ou can still sign-up and get a room at the hotel!!
******** 13th International Conference on Lyme Disease and ****************
***************Other Tick-Borne Disorders ***********************
************* Clinical Management & Research Update *************
Jointly Sponsored by The College of Physicians and Surgeons of Columbia
Universityand the Lyme Disease Foundation
Keynote Speakers: Attorney General Richard Blumenthal - Protecting the Public
Health
Willy Burgdorfer, PhD, MD (hon) - Discoverer of the pathogen
causing LD
Senator Christopher Dodd - United States Senate - CT
March 25 & 26, 2000 Farmington Marriott, Farmington, CT
Place: Hartford Marriott, Farmington, CT 800-228-9290
$79 single/double. Reserve your room now. The hotel is expected to
sell-out!
Rate applies 3/23 - 3/27 - for those who want a side trip, maybe to Lyme,
CT!
Travel: Huntington Hay Travel 800-783-9783. Bradley is the closest airport
with shuttle service to the hotel. However, there is also a shuttle service
from LaGuardia and Kennedy airports (3 hr ride).
****************** PROGRAM AGENDA *******
******** FRIDAY MARCH 24, 2000
• Light Reception and Registration 7 - 10 pm
***** SATURDAY MARCH 25, 2000
• Registration 7- 9am
• Program 8am - 5:30pm
• Reception 7-10pm
Presenters:
• Keynote: Richard Blumenthal, Attorney General of Connecticut
• West Nile Virus: Epicenter to epidemic and what to expect in 2000
Tracey McNamara, DVM, Diplomate ACVP National Wildlife Conservation / Bronx
Zoo
• West Nile in Connecticut
John Anderson, PhD Connecticut Agricultural Experiment Station
• Overview of human ehrlichioses and Rocky Mountain spotted fever in the US
Christopher Paddock, MD Centers for Disease Control and Prevention
• Babesiosis
Peter Krause, MD University of Connecticut School of Medicine
• Prevalence of infection in ticks submitted to the human test kit program of
the U.S. Army Center for Health Promotion and Preventive Medicine
Ellen Stromdahl, MS US Army Center for Health Promotion and Preventive
Medicine
• Analysis of Southern Borrelia
Angela James, PhD Centers for Disease Control and Prevention
• Coinfections
Louis Magnarelli, PhD Connecticut Agricultural Experiment Station
• Preliminary in vitro and in vivo findings of hyperbaric oxygen treatment in
experimental Bb infection
Charles Pavia, PhD NY Medical College School of Medicine, NYCOM
Microbiology and Immunodiagnostic
Laboratory of NYIT
• Immunity against host-adapted B. burgdorferi in the rabbit
James Miller, PhD UCLA School of Medicine
• Immunologic aspects of Vlse, a B. burgdorferi antigenic variation protein
Steve Norris, PhD University of Texas Medical School
• An immunodominant peptide of B. burgdorferi Vlse: Role in diagnosis &
pathogenesis
Mario Philipp, PhD Tulane University School of Medicine
• Antibiotic treatment of Lyme borreliosis: A review of results with dogs
Rheinhard Straubinger, DVM, PhD Cornell University School of Veterinary
Medicine
• A Bb repetitive antigen that confers protection against experimental LD
Jon Skare, PhD Texas A & M University System Health Science Center
• Use of the borreliacidal assay in the serodiagnosis of Lyme disease
Ronald Schell, PhD University of Wisconsin School of Medicine
• Lyme neuroborreliosis - The role of PCR and culture in the diagnosis and
in the confirmation of relapse after antibiotic treatment
Jarmo Oksi, MD, PhD Turku University Central Hospital, Department of
Medicine, Finland
• Laboratory Testing Panel
Mark Golightly, MD SUNY at Stony Brook School of Medicine
Eli Mordechai, PhD Medical Diagnostic Laboratories
Ronald Schell, PhD University of Wisconsin School of Medicine
Jyotsna Shah, PhD Igenex Laboratories
Richard Tilton, PhD BBI Clinicial Laboratories
Steven Schutzer, MD University of Medicine and Dentistry of New Jersey
SUNDAY MARCH 26, 2000
Registration 7-8am (CME Sign-in)
Program 8AM - 5PM
Presenters:
• Keynote Willy Burgdorfer, PhD, MD National Institutes of Health
• Characterization of an immune evasion system in the Lyme disease
spirochetes
Richard Marconi, PhD Medical College of Virginia
• Matrix metalloproteinases in Lyme disease
George Perides, PhD Beth Israel Deaconess Medical Center (Harvard)
• Interleukin-10 regulation during acute Lyme arthritis in dogs
Reinhard Straubinger, DVM, PhD Cornell University School of Veterinary
Medicine
• T-cell response
Adriana Marques, MD National Institutes of Health
• Protection against tick-transmitted disease in dogs vaccinated with a
multiantigenic vaccine
Alan Frey, PhD New York University School of Medicine
• Update on the SKB OspA vaccine
Dennis Parenti, MD SmithKline Beecham Biologicals
• Atypical EM and acute Lyme disease
Edwin Masters, MD Regional Primary Care Physicians
• Neurologic Lyme disease in adults
Patricia Coyle, MD SUNY at Stony Brook School of Medicine
• Neurologic Lyme disease in children and adolescents
Dorothy Pietrucha, MD, FAAP Jersey Shore Medical Center, Meridan Health
System
• Cognitive deficits in children and the public health/educational
implications
Marian Rissenberg, MD Columbia University School of Medicine
• Neuroimaging in neuropsychiatric Lyme disease: Uses, abuses, and the future
Brian Fallon, MD Columbia University College of Physicians & Surgeons
• Pharmacologic properties of antibiotics and their relevence to LD
Sam Donta, MD Boston University School of Medicine
• Treatment Roundtable
Joseph Burrascano, MD Southampton Hospital
Sam Donta, MD Boston University School of Medicine
Lesley Fein, MD Morristown Memorial Hospital
Kenneth Liegner, MD Westchester Medical Center
Dorothy Pietrucha, MD Cornell/NYHospital, Jersey Shore Medical Center
•••• Target Audience
This conference is designed for clinical professionals (including but not
limited to Primary Care Physicians, Nurse Practitioners, Physician Assistants,
Public Health Officers, Researchers and Veterinarians) and other health
professionals (medical directors, risk managers) who wish to enhance their
knowledge of Lyme disease and other tick-borne disorders.
••• Program Committee
James Miller, PhD UCLA School of Medicine
Sam Donta, MD Boston University School of Medicine
Brian Fallon, MD Columbia University College of Physicians & Surgeons
Ed Bosler, PhD Stonybrook School of Medicine
Julie Rawlings, MPH Texas Department of Health
Charles Pavia, PhD New York Medical College
Ronald Schell, PhD University of Wisconsin School of Medicine
••• Accreditation
This activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical
Education (ACCME) through the joint sponsorship of the College of Physicians &
Surgeons of Columbia University and the Lyme Disease Foundation.
The College of Physicians & Surgeons of Columbia University is accredited by
the Accreditation Council for Continuing Medical Education (ACCME) to sponsor
continuing medical education for physicians and takes responsibility for the
content, quality and scientific integrity of this CME activity.
The College of Physicians & Surgeons designates this educational activity for
a maximum of 15 hours in Category 1 credit towards the AMA Physician’s
Recognition Award. Each physician should claim only those hours of credit that
he/she actually spent in the educational activity.
•••• Conference Goals
a. Recognize the complex nature of Borrelia burgdorferi in both in terms of its
antigenic variability and the host response to infection;
b. Understand the rationale for different treatment approaches to Lyme Disease
in animals and humans;
c. Clarification of the role of the multiple diagnostic tests for Lyme disease;
d. Understanding better the presentations of neurologic Lyme disease in
children and adults, including the role of neuropsychological testing and
neuroimaging;
e. Understanding the epidemiology, clinical phenomenology, and diagnostic
methods for detecting other vector-borne diseases, such as babesiosis,
ehrlichiosis, Rocky Mountain spotted fever, and West Nile virus;
f. Understanding the latest research regarding Lyme vaccines.
Disclosure
Before the program, all faculty will disclose the existence of any financial
interest and/or other relationship(s) (e.g. employee, consultant, speaker’s
bureau, grant recipient, research support, stock ownership or any other special
relationship) they might have with a.) the manfacturer(s) of any commercial
product(s) to be discussed during their presentation and/or b.) any commercial
contributor to this activity. When unlabeled uses are discussed, these will
also be indicated.
***************** REGISTRATION *******************
Mail to: Lyme Disease Foundation, 1 Financial Plaza, Hartford, CT 06103
860-525-2000 Fax 860-525-8425 Hotline 800-886-LYME
Lymefnd at aol.com www.Lyme.org
Fee includes: Attendance at scientific sessions, book of proceedings, lunch and
breaks on both days, and receptions Friday (3/24) and Saturday (3/25) night.
__ $275 February 16 to March 21
__ $325 March 22 to on-site
__ $160 Poster Presenters - Posters still being accepted as of 3/7/00.
Contact us for forms ; Graduate Students - w/University validation letter.
__ $60 Reception Only
__ $20 CME Certificate
***** Check Enclosed - Make checks payable to “Lyme Disease Foundation”
**** Credit Card Charge
__ Mastercard __ Visa __ American Express
Card #_______________________________ Exp. ______
Signature________________________________________
Total Payment Enclosed: $ ____________
Full payment must accompany registration form.
** REGISTRANT #1
Name:
Title/Position:
Degree(s):
Institution:
Mailing Address:
City: State Zip
Phone:
fax;
email:
___ CME’s ___CME Certificate ($20 extra)
Signature
** REGISTRANT #2
Name:
Title/Position:
Degree(s):
Institution:
Mailing Address:
City: State Zip
Phone:
fax;
email:
___ CME’s ___CME Certificate ($20 extra)
Signature
